Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
Yearly, about 1.5 million people become chronically infected with hepatitis C virus (HCV) and for the 71 million with chronic HCV infection about 400,000 die from related morbidities, including liver cirrhosis and cancer. Effective treatments exist, but challenges including cost-of-treatment and wid...
Guardado en:
Autores principales: | Jannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, Louise Goksøyr, Rebecca W Olsen, Margherita Fanalista, Elias H Augestad, Susan Thrane, Anne F Pihl, Judith M Gottwein, Adam F Sander, Jens Bukh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/66c39541f9e1496cbb7f3e0e0d294e1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
por: Francesca Mancini, et al.
Publicado: (2021) -
CROSS-ANTIGENIC AND IMMUNOGENIC FEATURES OF CANONICAL AND NEW GENOGROUPS OF ENTEROVIRUS 71
por: R. Volle, et al.
Publicado: (2018) -
Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
por: Troels K H Scheel, et al.
Publicado: (2012) -
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity
por: Kwoneel Kim, et al.
Publicado: (2020) -
HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
por: Chelsea N. Fries, et al.
Publicado: (2021)